GFOD2
Basic information
Region (hg38): 16:67674531-67719339
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GFOD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 28 | 28 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 1 | 0 |
Variants in GFOD2
This is a list of pathogenic ClinVar variants found in the GFOD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-67675177-G-A | not specified | Uncertain significance (Sep 07, 2022) | ||
16-67675206-C-A | not specified | Uncertain significance (Dec 02, 2024) | ||
16-67675213-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
16-67675298-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
16-67675315-G-A | not specified | Uncertain significance (Dec 05, 2022) | ||
16-67675342-C-T | not specified | Uncertain significance (Nov 15, 2024) | ||
16-67675346-C-T | not specified | Uncertain significance (Nov 16, 2024) | ||
16-67675369-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
16-67675387-T-C | not specified | Uncertain significance (Dec 16, 2023) | ||
16-67675414-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
16-67675448-C-T | not specified | Uncertain significance (May 09, 2023) | ||
16-67675450-C-A | not specified | Uncertain significance (Aug 10, 2024) | ||
16-67675489-G-A | not specified | Uncertain significance (Jun 08, 2022) | ||
16-67675538-G-A | not specified | Uncertain significance (Nov 11, 2024) | ||
16-67675577-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
16-67675645-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
16-67675664-C-T | not specified | Uncertain significance (Dec 27, 2022) | ||
16-67675679-G-A | not specified | Uncertain significance (Sep 14, 2021) | ||
16-67675730-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
16-67675777-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
16-67675816-C-G | not specified | Uncertain significance (Mar 22, 2022) | ||
16-67675874-T-A | not specified | Uncertain significance (Aug 30, 2021) | ||
16-67675892-A-G | not specified | Uncertain significance (Feb 27, 2024) | ||
16-67675899-C-T | Likely benign (Jun 01, 2022) | |||
16-67675919-G-A | not specified | Uncertain significance (Oct 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GFOD2 | protein_coding | protein_coding | ENST00000268797 | 2 | 44891 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0466 | 0.931 | 125728 | 0 | 20 | 125748 | 0.0000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.01 | 216 | 262 | 0.824 | 0.0000174 | 2487 |
Missense in Polyphen | 69 | 89.205 | 0.7735 | 867 | ||
Synonymous | 0.858 | 104 | 116 | 0.899 | 0.00000813 | 831 |
Loss of Function | 1.99 | 4 | 11.2 | 0.358 | 6.48e-7 | 113 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000968 | 0.0000967 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Promotes matrix assembly. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.565
- rvis_EVS
- -0.67
- rvis_percentile_EVS
- 15.76
Haploinsufficiency Scores
- pHI
- 0.222
- hipred
- N
- hipred_score
- 0.459
- ghis
- 0.587
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.365
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gfod2
- Phenotype
Gene ontology
- Biological process
- extracellular matrix organization;oxidation-reduction process
- Cellular component
- extracellular matrix
- Molecular function
- oxidoreductase activity